Financhill
Back

Cara Therapeutics Stock Predictions

Cara Therapeutics Stock Forecast

  • Is Cara Therapeutics Stock Undervalued?
    The current Cara Therapeutics [CARA] share price is $0.42. The Score for CARA is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • CARA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Cara Therapeutics Stock Go Up Next Year?

Data Unavailable

Cara Therapeutics Stock Rating

Data Unavailable

Cara Therapeutics Stock Price History

Is CARA stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CARA is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
caratherapeutics.com

52-Week Data

52-Week High:
1.15
52-Week Low:
0.23

Prediction Charts

Market Cap:
23.2M
Price in USD:
0.42
Volume:
5.3M
Beta:
1.18

Technical Analysis

SMA50:
0.29
SMA100:
0.30
SMA200:
0.47
52-Wk Change:
-30.34%

Stock Predictions

  • Is Cara Therapeutics stock public?
    Yes, Cara Therapeutics is a publicly traded company.
  • What is the Cara Therapeutics stock quote today?
    The Cara Therapeutics stock price is 0.42 USD today.
  • How to buy Cara Therapeutics stock online?
    You can buy Cara Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 0.29 0.28 0.29 0.28
Dec-4 0.29 0.27 0.29 0.26
Dec-5 0.27 0.27 0.28 0.26
Dec-6 0.28 0.27 0.28 0.26
Dec-9 0.26 0.29 0.30 0.26
Dec-10 0.29 0.27 0.29 0.27
Dec-11 0.29 0.27 0.29 0.27
Dec-12 0.26 0.26 0.28 0.26
Dec-13 0.28 0.26 0.28 0.24
Dec-16 0.25 0.26 0.27 0.25
Dec-17 0.25 0.25 0.26 0.24
Dec-18 0.24 0.26 0.27 0.23
Dec-19 0.26 0.41 0.52 0.25
Dec-20 0.34 0.42 0.46 0.34

Cara Therapeutics Earnings

Data Unavailable

Cara Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.41 per share, and an increase next year of $0.25 per share.

* Cara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.